The European Commission is set to announce its decision on the proposed acquisition of contract drug manufacturer Catalent by Novo Holdings, the primary shareholder of pharmaceutical giant Novo Nordisk, by December 6, 2024. This follows an official submission for approval filed by Novo Holdings on October 31, as noted on the Commission’s website. The decision […]
Continue Reading
The European Commission has accused Indian pharmaceutical company Alchem International of participating in a cartel to fix the prices of a key pharmaceutical ingredient, a move that could result in significant financial penalties for the company. The Commission, acting as the European Union’s competition watchdog, has issued a statement of objections to Alchem, detailing its […]
Continue Reading
The Effexor XR Antitrust Litigation, centered around allegations of collusion between pharmaceutical giant Pfizer’s predecessor, Wyeth, and competitor Teva, has taken a significant turn with Pfizer’s agreement to a $25.5 million settlement. This settlement aims to address claims of conspiring to delay the release of a more affordable generic version of the widely-used antidepressant Effexor […]
Continue Reading